Day: May 17, 2021

Call Scheduled for 11:00 a.m. Eastern Time on Wednesday, May 26, 2021 DALLAS, May 17, 2021 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest” or the “Company”; Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, announced today that it will release its fourth quarter and fiscal year 2021 results on Tuesday, May 25, 2021 after the market closes. In conjunction with the release, Capital Southwest has scheduled a conference call which will be broadcast live via phone and over the Internet on Wednesday, May 26, 2021 at 11:00 a.m. Eastern time. Investors may participate either by phone or audio webcast. By Phone: Dial (866)-502-8274 and provide the operator with Conference ID 6354954...

Advicenne reçoit un avis positif de la FDA sur la procédure d’approbation et l’Agence accepte le protocole modifié de l’étude de phase III pour son traitement de l’acidose tubulaire rénale distale (ATRd)La FDA accepte le protocole modifié et Advicenne reprendra l’essai de phase III de son produit phare ADV7103 (Sibnayal™) aux Etats-Unis en juin 2021Les recommandations de la FDA indiquent clairement la voie à suivre en vue de l’obtention de l’autorisation de mise sur le marché d’ADV7103 aux Etats-UnisParis, France, le 17 mai 2021 à 18h (CEST) – Advicenne (Euronext : ADVIC), société pharmaceutique spécialisée dans le développement et la commercialisation de traitements innovants pour les personnes souffrant de maladies rénales rares, annonce l’acceptation par la Food and Drug Administration...

Millennium bcp Earnings release as at 31 March 2021AttachmentsEarnings Millennium bcp 1Q21_vEarningsPres Q1’21

2021 Global InfoSec Award WinnerAware’s Knomi won Best Product in Passwordless Authentication during the 2021 Global InfoSec Awards.Cyber Defense Magazine recognizes Knomi in 2021 Global InfoSec Awards at RSA Conference BEDFORD, Mass., May 17, 2021 (GLOBE NEWSWIRE) — Aware, Inc., (NASDAQ: AWRE), a leading global provider of biometric-based authentication software products, solutions and services, is pleased to announce that it has received a prestigious 2021 Global InfoSec Award from Cyber Defense Magazine for its Knomi™ mobile biometric authentication platform. Knomi was named as the winner for Best Product in Passwordless Authentication due to its field proven capability to protect against cybersecurity threats by replacing theft-prone passwords with secure biometric authentication technology. Knomi is...

Advicenne receives positive feedback from the US FDA on pathway to approval and amended Phase III study protocol for its treatment of distal renal tubular acidosis (dRTA)FDA accepts amended protocol and Advicenne will resume Phase III trial of its lead product ADV7103 (Sibnayal™) in the US in June 2021FDA guidance provides clear path for market approval of ADV7103 in the United StatesParis, France, 17 May 2021 – 6 pm CEST – Advicenne (Euronext: ADVIC), a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for those suffering from rare renal diseases, announces US Food and Drug Administration (FDA) acceptance of the amended protocol of the Company’s US-based Phase III pivotal trial of ADV7103 (Sibnayal™) for the treatment of primary distal renal tubular acidosis (dRTA). dRTA is an orphan...

Shareholders’ Meeting set for June 29, 2021 Wendel informs its shareholders that, given the current evolutive Covid-19 pandemic and the measures preventing its spread, the Wendel Shareholders’ Meeting will be held on June 29, 2021 at 2:00 p.m. in closed session, in the framework of Order n°2020-321 dated March 25, 2020 adjusting rules applying to shareholders’ meetings, as amended and extended until July 31, 2021, in particular through Decree n°2021-255 dated March 9, 2021. The Executive Board made this decision considering the administrative measures limiting or banning travel or gathering due to health concerns, which are preventing the physical presence of members and participants to the Meeting. These measures cap the number of participants to collective gatherings and affect in particular the conference room booked for the Meeting,...

Communiqué de presse – lundi 17 mai 2021 – 17h45 ARGAN fait l’acquisition auprès de CARREFOURde 3 entrepôts totalisant 70.000 m² Ces trois entrepôts seront logés dans une SCI commune ARGAN-CARREFOUR destinée au développement de futurs entrepôts logistiques loués notamment à CARREFOUR. La création de cette SCI commune, portée à 60% par ARGAN et 40% par le groupe CARREFOUR, s’inscrit dans le prolongement de l’acquisition en 2019 par ARGAN, auprès du groupe CARREFOUR, de 22 entrepôts logistiques représentant une surface de 1,1 million de m². Les trois nouveaux entrepôts acquis auprès du groupe CARREFOUR se situent à Lens (62), Marseille (13) et au Plessis-Pâté (91) et représentent une surface de l’ordre de 70.000 m². L’entrepôt du Plessis-Pâté, d’une surface de 24.500 m² est loué en totalité à CARREFOUR et les sites de Lens et Marseille...

PRESS RELEASE May 17th, 2021 Aéroports de Paris SAApril 2021 traffic figures Groupe ADP total traffic1 is up by 6.8 million passengers in April 2021 compared to April 2020, with 7.1 million passengers welcomed for the entire network of operated airports. It stands at 25.7% of the April 2019 group traffic1. In April 2021, at Paris Aéroport alone, the traffic increased by 1.2 million of passengers compared to April 2020, with 1.3 million passengers welcomed. It stands at 13.9% of the April 2019 Paris Aéroport traffic. Paris-Charles de Gaulle welcomed 0.9 million passengers in April 2021 (+0.8 million passengers2, at 14.1% of the April 2019 traffic) and Paris-Orly 0.4 million passengers (+0.4 million passengers2, at 13.4% of the April 2019 traffic). At Paris-Charles de Gaulle, only terminals 2E and 2F are currently opened in order to handle...

Sales for Q1 2021: €104.4m, down 1% from Q1 2020 Net margin for Q1 2021: €10.9m, up €1.2m from Q1 2020 Normalised profit before tax in Q1 2021: €3.7m, up €0.8m from Q1 2020 Net profit for Q1 2021: €2.7m compared to €1.9m in Q1 2020 Basic earning per share (EPS) for Q1 2021 were €0.1017 cents per thousand shares compared to €0.0722 cents per thousand shares for Q1 2020 Balance sheet reflecting seasonally high inventories in S-Europe and increased receivables due to strong sales in March. Total assets of €261.5m at end of March LOI signed to acquire a 80% stake in Ahumados Dominguez in Spain Normalised PBT Outlook range of €12.0-17.0m for 2021, based on a scenario that sales and profitability will resume to normal conditions in second half of 2021Encouraging outcome of Q1 with normalised PBT of €3.7m compared to €2.9m in Q1 2020. Group...

West Palm Beach, FL, May 17, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Ethema Health Corporation (OTCPINK: GRST) (“Ethema” “GRST” or the “Company”) is pleased to announce that the Company has made a substantial change to its debt position.  The details have been released in an 8-K filed today with the SEC.  At the end of April, payments on one of the Company’s convertible notes were due in addition to the expiration of the rights of repayment on several of the other convertible notes owed by the Company.  As part of the Company’s focus on dealing with its debt announced on April 28, 2021, the Company closed on a one-year convertible note in the face amount of $550,000.00 including an OID of 10% and a fixed conversion price of $0.005 per share.  The Company used the proceeds of the loan to repay three of its lenders notes...